Studies on epigenetic markers—particularly DNA methylation of pivotal genes such as F2RL3 and AHRR, as well as alterations in miRNA profiles affecting gene expression—have emerged as significant indicators for diagnosing and treating lung cancer. The gene discussed is F2RL3; the disease is lung cancer.